Akhil Chopra

Hematology

1331 E Wyoming Ave
Philadelphia, PA 19124

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552].

Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552].

Journal: Journal of hepatology

Published: November 01, 2019

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.

Journal: Journal of hepatology

Published: November 06, 2018

Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA.

Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 03, 2018

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 28, 2018

Outcome of advanced lung cancer with central airway obstruction versus without central airway obstruction.

Outcome of advanced lung cancer with central airway obstruction versus without central airway obstruction.

Journal: ERJ open research

Published: January 02, 2018

Povidone-iodine for the management of oral mucositis during cancer therapy.

Povidone-iodine for the management of oral mucositis during cancer therapy.

Journal: Oncology reviews

Published: April 26, 2017

Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison.

Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison.

Journal: The Prostate

Published: November 24, 2016

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.

Journal: Lancet (London, England)

Published: November 23, 2016

Significance of coexistent granulomatous inflammation and lung cancer.

Significance of coexistent granulomatous inflammation and lung cancer.

Journal: Journal of clinical pathology

Published: May 13, 2016

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.

Journal: Current drug discovery technologies

Published: April 19, 2016

Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life.

Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: September 07, 2015

Timeliness of Diagnosing Lung Cancer: Number of Procedures and Time Needed to Establish Diagnosis: Being Right the First Time.

Timeliness of Diagnosing Lung Cancer: Number of Procedures and Time Needed to Establish Diagnosis: Being Right the First Time.

Journal: Medicine

Published: July 23, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026